Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Fzd2 is important for skin and hair development through various signaling ways.

Vitamin D might help treat alopecia areata.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Hydrogel scaffolds can help wounds heal better and grow hair.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.